Redefining Panfacial Rejuvenation: A Paradigm Shift Employing the Volumetric Structural Rejuvenation Approach

 

Release Date: April 29, 2019

Last Reviewed: April 24, 2019

Expiration Date: April 29, 2020

Time to Complete Activity: 0.75 hours

Clinical Professor of Dermatology

Department of Dermatology

Weill Cornell Medical College

Medical Director

Sadick Research Group

New York, NY

 

Volunteer Assistant Clinical Professor

Department of Medicine/Dermatology

University of California, San Diego

Goldman Butterwick Fitzpatrick Groff and Fabi Cosmetic Laser Dermatology

San Diego, CA

This activity is provided by Paradigm Medical Communications, LLC.  

 

This activity has been designed to address the educational needs of dermatologists, dermatologic surgeons, plastic surgeons, facial plastic surgeons, oculoplastic surgeons, ophthalmologists, otolaryngologists, nurse practitioners, and PAs. It may also be of benefit to other physicians, nurses, and healthcare providers who are involved in the field of aesthetic medicine.

 

Optimal use of injectable agents is based on comprehensive knowledge of the anatomic changes seen with facial aging, the products to be used, and the latest techniques. The Volumetric Structural Rejuvenation approach to panfacial rejuvenation utilizes new generation soft tissue fillers and a bimodal (2-step), trivector (3 injection site) technique based on sequential repletion of the deep fat pads with depot injections, followed by more superficial injections to correct localized areas of volume loss, customize contours, and create facial symmetry. Neuromodulators and other modalities are then selectively used as part of a refined, individualized treatment plan agreed upon by both physician and patient. This activity has been designed to educate aesthetic clinicians on how to effectively and safely select and use available soft tissue fillers and neuromodulators to facilitate natural, harmonious, panfacial rejuvenation.

 

Upon proper completion of this activity, participants should be better able to:

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Paradigm Medical Communications, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PAs may claim a maximum of 0.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
 

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
 

This activity is supported by an educational grant from Allergan, Inc.

 

To receive a CME certificate of participation, you should:

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.

 

There is no fee required for participation in this activity.

This certified CME activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.

 

For Desktops (Windows/Mac)

Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher

 

For Tablets (iPad/Android/Surface)

iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
 

Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.

 

In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.

 

Advisory Board: Allergan, Inc

Consultant: Allergan, Inc; Almirall, S.A.; Galderma Laboratories, L.P.; Venus Concept

Stockholder: Vascular Insights, LLC

 

Consultant: Alastin Skincare, Inc; Allergan, Inc.; Colorscience, Inc.; Endo Pharmaceuticals Inc.; EVOLUS; Galderma Laboratories, L.P.; Merz North America, Inc.; Revance Therapeutics, Inc; ThermiGen, LLC; Valeant Pharmaceuticals International, Inc

Speakers’ Bureau: Alastin Skincare, Inc; Allergan, Inc.; EVOLUS; Galderma Laboratories, L.P.; Merz North America, Inc.; ThermiGen, LLC; Valeant Pharmaceuticals International, Inc

Grant/Research Support: Alastin Skincare, Inc; Allergan, Inc.; Ampersand Aesthetics; Bayer HealthCare; Colorscience, Inc.; Endo Pharmaceuticals Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.; Revance Therapeutics, Inc

Stockholder: Allergan, Inc.; Revance Therapeutics, Inc

 

Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose.

 

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.

 

This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

 

As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. In this activity, the trade names for neuromodulators and soft tissue fillers may be used for clarity. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.

 

The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.

 

Paradigm Medical Communications, LLC is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website"). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

 

This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

 

The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.

 

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

 

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.

 

© 2019 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.